pastillas glp 1 para que sirve FDA acaba de aprobar la primera PASTILLA de GLP1 el tratamiento de la obesidad. Se llama Orfoglipron (Foundayo TM). Una alternativa práctica con mayor adherencia terapéutica . Fuente FDA . #orfoglipron#obesidad brain cell function and reduce fatigue for those low in B12 💊Nuevo medicamento para la obesidad
Description
For patients with significant insulin resistance, type 2 diabetes, or metabolic syndrome, the dual-action mechanism often delivers noticeably stronger results
But these medications do far more than help people shed pounds

This is manageable with regular thyroid lab monitoring and dose adjustmentsyour doctor should recheck thyroid function within 6-8 weeks of starting GLP-1 therapy

Check current FDA guidance for the latest regulatory status

References Hirsch LJ, Strauss KW
56 ReinerD
